Treitl Daniela, Hurtado Michael, Ben-David Kfir
Department of Surgery, Comprehensive Cancer Center, Mount Sinai Medical Center , Miami Beach, Florida.
J Laparoendosc Adv Surg Tech A. 2016 Apr;26(4):276-80. doi: 10.1089/lap.2016.0088. Epub 2016 Apr 5.
Adenocarcinoma of the esophagus continues to increase in incidence and has become a significant health problem in Western countries. While mortality rates are slowly improving from this disease, multimodality treatment, including esophagectomy, has remained critical for optimal outcomes. Esophagectomy has been described as an operation with significant morbidity and mortality, but over the last decade, increased utilization of minimally invasive esophagectomy in an effort to reduce the high rates of morbidity and lengthy hospital stays associated with open esophagectomy has been adopted at many medical centers. We review esophageal cancer treatment modalities, considerations in the current context of neoadjuvant therapy, and increased adoption of minimally invasive approaches.
食管癌的发病率持续上升，已成为西方国家一个重大的健康问题。虽然该疾病的死亡率正在缓慢下降，但包括食管切除术在内的多模式治疗对于实现最佳治疗效果仍然至关重要。食管切除术被描述为一种具有较高发病率和死亡率的手术，但在过去十年中，许多医疗中心采用了增加微创食管切除术的使用，以降低与开放食管切除术相关的高发病率和较长住院时间。我们回顾了食管癌的治疗方式、新辅助治疗当前背景下的注意事项以及微创方法的更多应用。
